1-9 of 9
Cecele J Denman
Close
Sort by
Journal Articles

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Clinical Trials & Observations
Stefan O. Ciurea, Jolie R. Schafer, Roland Bassett, Cecele J. Denman, Kai Cao, Dana Willis, Gabriela Rondon, Julianne Chen, Doris Soebbing, Indreshpal Kaur, Alison Gulbis, Sairah Ahmed, Katayoun Rezvani, Elizabeth J. Shpall, Dean A. Lee, Richard E. Champlin
Journal: Blood
Blood (2017) 130 (16): 1857–1868.
https://doi.org/10.1182/blood-2017-05-785659
Published: 2017
Includes: Supplemental data
Journal Articles

Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation

Shiguo Zhu, Prasad V. Phatarpekar, Cecele J. Denman, Vladimir V. Senyukov, Srinivas S. Somanchi, Hoainam T. Nguyen-Jackson, Emily M. Mace, Alexandra F. Freeman, Stephanie S. Watowich, Jordan S. Orange, Steven M. Holland, Dean A. Lee
Journal: Blood
Blood (2014) 124 (3): 403–411.
https://doi.org/10.1182/blood-2013-05-499707
Published: 2014
Journal Articles

Chemokine Receptor Expression, Migration, and Survival of NK Cells Expanded with Mbil-15 or Mbil-21

Dean Lee, Maureen Aliru, Cecele J. Denman, Srinivas S. Somanchi, PhD
Journal: Blood
Blood (2012) 120 (21): 4683.
https://doi.org/10.1182/blood.V120.21.4683.4683
Published: 2012
Journal Articles

STAT3 Activation Promotes NK Cell Proliferation, NKG2D Expression, and NK Cell Antitumor Activity

Prasad Phatarpekar, Shiguo Zhu, MD, PhD, Cecele J. Denman, Nam Nguyen-Jackson, Stephanie S. Watowich, PhD, Laurence J.N. Cooper, MD, PhD, Dean A. Lee, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 105.
https://doi.org/10.1182/blood.V116.21.105.105
Published: 2010
Journal Articles

Valproic Acid Selectively Inhibits STAT3 Phosphorylation.

Shiguo Zhu, PhD, Cecele J Denman, MS, Dean A. Lee, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1720.
https://doi.org/10.1182/blood.V114.22.1720.1720
Published: 2009
Journal Articles

5-Aza-2'-Deoxycytidine Has a Biphasic Effect On Ex Vivo Expanded Natural Killer Cells.

Lisa M. Kopp, DO, Cecele J. Denman, MS, Shiguo Zhu, PhD, Dean A. Lee, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2664.
https://doi.org/10.1182/blood.V114.22.2664.2664
Published: 2009
Journal Articles

The Contribution of Signaling Endodomains to CD33-Mediated Killing of Acute Myeloid Leukemia by Natural Killer Cells Transiently Modified with Chimeric Antigen Receptor.

Jeffrey Friesen, Vladimir Senyukov, PhD, Cecele J Denman, Srinivas S. Somanchi, PhD, Simon Olivares, BS, Laurence J.N. Cooper, MD PhD, Dean A. Lee, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2463.
https://doi.org/10.1182/blood.V114.22.2463.2463
Published: 2009
Journal Articles

Gene Modification of Human Primary Natural Killer Cells by Electroporation with mRNA or DNA Coding for An Anti-GD2 Chimeric Antigen Receptor.

Srinivas S. Somanchi, Ph.D, Cecele J Denman, MS, Atharva Amritkar, Vladimir Senyukov, Ph.D, Simon Olivares, BS, Laurence J.N Cooper, MD, Ph.D, Dean A. Lee, MD, Ph.D
Journal: Blood
Blood (2009) 114 (22): 2467.
https://doi.org/10.1182/blood.V114.22.2467.2467
Published: 2009
Journal Articles

Sustained Ex Vivo Expansion of Human Peripheral Blood NK Cells Using Artificial APCs Bearing Membrane-Bound IL-21.

Cecele J Denman, MS, Lisa M. Kopp, DO, Vladimir Senyukov, PhD, Sarah Hagemeister, Jennifer Johnson, Maria A Lima Da Silva, Harjeet Singh, PhD, Lenka Hurton, Simon Olivares, BS, Mary Helen Huls, BS, Richard E Champlin, MD, Laurence J.N. Cooper, MD, PhD, Dean A. Lee, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3030.
https://doi.org/10.1182/blood.V114.22.3030.3030
Published: 2009